TI
KNSA icon

Trexquant Investment’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Trexquant Investment’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Sell
53,507
-81,773
-60% -$4.24M 0.02% 940
2026
Q1 		$6.51M Sell
135,280
-89,848
-40% -$3.98M 0.05% 548
2025
Q4 		$9.29M Sell
225,128
-134,710
-37% -$5.4M 0.08% 334
2025
Q3 		$14M Sell
359,838
-97,149
-21% -$3.16M 0.14% 156
2025
Q2 		$12.6M Buy
456,987
+220,504
+93% +$5.61M 0.14% 192
2025
Q1 		$5.25M Buy
236,483
+155,641
+193% +$3.2M 0.06% 486
2024
Q4 		$1.6M Sell
80,842
-74,350
-48% -$1.7M 0.02% 947
2024
Q3 		$3.88M Sell
155,192
-46,523
-23% -$1.13M 0.05% 574
2024
Q2 		$3.77M Buy
201,715
+127,809
+173% +$2.39M 0.06% 495
2024
Q1 		$1.46M Buy
73,906
+2,356
+3% +$46K 0.03% 772
2023
Q4 		$1.25M Sell
71,550
-5,273
-7% -$86.7K 0.03% 736
2023
Q3 		$1.33M Sell
76,823
-9,273
-11% -$156K 0.03% 639
2023
Q2 		$1.21M Buy
86,096
+45,898
+114% +$614K 0.03% 695
2023
Q1 		$433K Sell
40,198
-25,184
-39% -$332K 0.01% 1057
2022
Q4 		$979K Buy
65,382
+8,572
+15% +$125K 0.03% 650
2022
Q3 		$729K Buy
+56,810
New +$647K 0.03% 647

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Trexquant Investment's KNSA Position: Q2 2026 in Review

Trexquant Investment reduced its Kiniksa Pharmaceuticals (KNSA) stake by 60% in Q2 2026, selling an estimated $4.24M and leaving 53,507 shares worth $3.42M. The position accounts for 0.02% of the portfolio, ranked #940.

Trexquant Investment first reported a position in KNSA in Q3 2022 and has held it in 16 quarters since. The position peaked at $14M in Q3 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Trexquant Investment held 53,507 shares of Kiniksa Pharmaceuticals worth $3.42M as of Q2 2026.
  • Trexquant Investment sold 81,773 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $4.24M.
  • Kiniksa Pharmaceuticals made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #940 holding.
  • Trexquant Investment first reported a position in Kiniksa Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Trexquant Investment's Kiniksa Pharmaceuticals position peaked at $14M in Q3 2025.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.